First Time Loading...

Beijing Strong Biotechnologies Inc
SZSE:300406

Watchlist Manager
Beijing Strong Biotechnologies Inc Logo
Beijing Strong Biotechnologies Inc
SZSE:300406
Watchlist
Price: 18.49 CNY 4.17% Market Closed
Updated: Apr 29, 2024

Beijing Strong Biotechnologies Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beijing Strong Biotechnologies Inc
Cash from Investing Activities Peer Comparison

Comparables:
6160
1801
603392
S
002252
300122

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Strong Biotechnologies Inc
SZSE:300406
Cash from Investing Activities
-¥127.2m
CAGR 3-Years
51%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Investing Activities
¥2.4B
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash from Investing Activities
-¥1.1B
CAGR 3-Years
41%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Investing Activities
-¥2.1B
CAGR 3-Years
-91%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
S
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Cash from Investing Activities
-¥36.1m
CAGR 3-Years
44%
CAGR 5-Years
N/A
CAGR 10-Years
19%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Investing Activities
-¥993.8m
CAGR 3-Years
-10%
CAGR 5-Years
-18%
CAGR 10-Years
-14%

See Also

What is Beijing Strong Biotechnologies Inc's Cash from Investing Activities?
Cash from Investing Activities
-127.2m CNY

Based on the financial report for Dec 31, 2023, Beijing Strong Biotechnologies Inc's Cash from Investing Activities amounts to -127.2m CNY.

What is Beijing Strong Biotechnologies Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
12%

Over the last year, the Cash from Investing Activities growth was 71%. The average annual Cash from Investing Activities growth rates for Beijing Strong Biotechnologies Inc have been 51% over the past three years , 12% over the past five years .